Feller Faye 4
4 · GERON CORP · Filed Jun 7, 2024
Insider Transaction Report
Form 4
GERON CORPGERN
Feller Faye
EVP, Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2024-06-06+200,000→ 200,000 totalExercise: $1.93Exp: 2032-07-07→ Common Stock (200,000 underlying) - Award
Employee Stock Option (right to buy)
2024-06-06+50,000→ 50,000 totalExercise: $1.06Exp: 2032-02-15→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Performance-based stock option granted on February 16, 2022 and vested in full on June 6, 2024 upon approval by the US FDA for imetelstat in lower risk MDS.
- [F2]Performance-based stock option granted on July 9, 2022 and vested in full on June 6, 2024 upon approval by the US FDA for imetelstat in lower risk MDS.